News & Blog

Catch the latest

Announcements
Blog: Octave Note
Media Library

Recent Announcements & Press

Sep 07th, 2023

Delivering Precision Care to Manage Neurodegenerative Diseases – MedCity News

Sep 06th, 2023

Octave® Bioscience, Inc. Announces Real-World Study Using its Multimodal Precision Care Solution for Multiple Sclerosis Patient Management

Aug 30th, 2023

Octave® Bioscience, Inc. Announces Publication of Clinical Validation Study Results of its Novel, Multivariate Multiple Sclerosis Disease Activity (MSDA) Blood Test – Businesswire

Aug 24th, 2023

Octave’s Solution for Transforming the Care Paradigm in MS has been Selected as a Finalist in Fast Company’s 2023 Innovation by Design Awards

Jul 26th, 2023

Octave Bioscience Closes $30M Extension to Series B Funding, Adds New Strategic Investors Following Strong Growth and Momentum – Businesswire

Jun 02nd, 2023

Octave Presents New Data at CMSC Annual Meeting 2023, Adding to Growing Evidence Supporting All Dimensions of its Comprehensive Precision Care Solution for Multiple Sclerosis – Businesswire

Mar 21st, 2023

Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis – Proteomics Clinical Applications

Feb 25th, 2023

Octave Presents Data from Nine Company and Partner Abstracts at ACTRIMS Forum 2023 – Businesswire

Nov 08th, 2022

Octave’s Precision Care Solution Aims to Better Tailor MS Treatment – MS News Today

Oct 28th, 2022

Octave Presents Data from 13 Abstracts at ECTRIMS Forum 2022 Following Commercial Launch of Precision Care Solution for Multiple Sclerosis – Businesswire

Oct 26th, 2022

Octave Commercially Launches a First-in-Class Precision Care Solution for Multiple Sclerosis – Businesswire

Sep 08th, 2022

Precision Medicine Marshals Its Resources – GEN

Aug 25th, 2022

How To Tell a Compelling Story To Motivate Others – Fast Company

Jun 07th, 2022

Blood Test to Monitor MS Activity Supports Optimal Care – MS News Today

Jun 03rd, 2022

Octave Presents Data at the CMSC 2022 Annual Meeting Showing its Multiple Sclerosis Disease Activity Biomarker Test Produces Clinical Practice Population Insights – Businesswire

Apr 02nd, 2022

Precision Care Solutions for Multiple Sclerosis – Nature

Mar 23rd, 2022

Multiple Sclerosis: Systemic Challenges to Cost-Effective Care – AHDB

Mar 07th, 2022

ViVE 2022: Making Value-Based Care a Widespread Reality in Healthcare – HealthTech Magazine

Mar 02nd, 2022

Octave Bioscience Building Evidence Base for Multiple Sclerosis Test to Support Clinical Launch – 360Dx

Feb 25th, 2022

Octave Presents Clinical Validation Results of its Multivariate Blood-based Multiple Sclerosis Disease Activity Biomarker Test at ACTRIMS Forum 2022

Feb 24th, 2022

ACTRIMS 2022 | A multivariate proteomic assay for disease activity assessments in MS – VJ Neurology

Oct 21st, 2021

Female Founders: Melinda Thomas of Octave Bioscience On The Five Things You Need To Thrive and Succeed as a Woman Founder – Authority Magazine

Oct 11th, 2021

Octave Bioscience Announces Strategic Investment from Merck Global Health Innovation Fund

Jul 13th, 2021

Personalized Approach to Measuring and Managing MS and Other Neurodegenerative Diseases with Bill Hagstrom Octave Bioscience

Mar 17th, 2021

Octave Welcomes Maital Shemesh-Rasmussen as Chief Commercial Officer

Dec 17th, 2020

Octave Bioscience Announces $32 Million Series B Financing

Octave Note

Feb 21st, 2023

ACTRIMS Preview: Advancing the Science for Patients with MS

Jan 09th, 2023 , Octave

Barriers in MS Treatment Adherence

Dec 12th, 2022 , Ferhan Qureshi

Leveraging Biology for Better Informed Treatment Decisions

Nov 29th, 2022

Precision Medicine: Biomarkers as an Objective Measure

Nov 08th, 2022

Octave at ECTRIMS: An Overview of Scientific Research Presented on Our MS Precision Care Solution

Oct 24th, 2022

ECTRIMS Preview: A Strong Presence at an Important Meeting

Oct 11th, 2022 , Kelly Leyden

MRI: Raising the Bar

Sep 26th, 2022

MRI: An Imperfect Gold Standard

Media Library

Bridging MS: Connecting You to Resources

Series sponsored by Octave. Navigating life with multiple sclerosis? Gain valuable insights from MS insiders! On the latest MS Living Well podcast, Dr. Barry Singer connects with Stanford nurse practitioner Jong-Mi Lee, MS patient advocate Dominic Shadbolt, and MS Neurologist MS Dr. Jaime Imitola for their perspectives and advice.

Listen

MRI in MS: From Pixels to Progress

Series sponsored by Octave. Step into the powerful realm of MRI imaging, providing us with an unparalleled view of multiple sclerosis. On the latest MS Living Well podcast, sponsored by Octave, Dr. Barry Singer & special guests, Dr. Christina Azevedo and Dr. Robert Zivandinov, discuss advances in techniques and where and how often to get MRI scans.

Listen

Multiple Sclerosis in Childhood

Series sponsored by Octave. Yes, children can get MS. Accurate diagnosis requires screening and evaluating risk factors. On the latest MS Living Well podcast, Dr. Barry Singer & special guests Dr. Brenda Banwell and Dr. Emmanuelle Waubant discuss pediatric MS.

Listen

Being Diagnosed with Multiple Sclerosis

Series sponsored by Octave. Trying to confirm if you have multiple sclerosis can be a frustrating process. Dealing with a new diagnosis of MS can be overwhelming. On the latest MS Living Well podcast, Dr. Barry Singer & special guests Gamboa and Dr. Jakai Nolan shed light on a positive path forward in living with multiple sclerosis.

Listen

Earliest Stages of Multiple Sclerosis

Series sponsored by Octave. Years before the first typical neurological symptoms of MS, such as numbness or visual loss, individuals can have other symptoms that are often overlooked. On the latest MS Living Well podcast, Dr. Barry Singer & special guests, Dr. Helen Tremlett and Dr. Erin Longbrake discuss awareness of this stage, known as prodrome, which may lead to earlier detection of MS.

Listen

Is My MS Controlled?

Series sponsored by Octave. Knowing which MS changes are significant enough to warrant speaking up about can be hard for patients to determine. On the latest MS Living Well podcast, Dr. Barry Singer & special guests, Dr. Jacqueline Nicholas and Dr. James Bowen discuss tools to improve monitoring such as biomarker blood testing.

Listen

Women to Watch Media with Susan Rocco

Interview with Co-Founder and COO, Melinda Thomas where she discussed the path to Octave, and how her call to "respond to the need" led to tackling the most complex neurological disease.

Watch

Personalized Medicine for MS

Series sponsored by Octave. Personalized medicine is now being applied to multiple sclerosis (MS), bringing the promise of improved care to patients and their loved ones. On the latest MS Living Well podcast, sponsored by Octave, Dr. Barry Singer & special guests, Dr. Celia Oreja-Guevara and Dr. Foley, discuss insights into treatment selection.

Listen

Digital Health & MS

Series sponsored by Octave. The way we measure the impact of multiple sclerosis (MS) on daily life has remained relatively unchanged for decades, but the emergence of digital health extends care beyond clinic visits. On the latest MS Living Well podcast, Dr. Barry Singer & special guests, Jennifer Graves and Tjalf Zeimssen discuss digital health and MS.

Listen

Vision & Multiple Sclerosis

Series Sponsored by Octave. Vision problems are one of the most common symptoms of multiple sclerosis & often one of the first that people with MS notice, with 70% of MS patients developing optic neuritis. On the latest MS Living Well podcast, Dr. Barry Singer & special guests, Anneke Van Der Walt & Tariq Bhatti discuss vision problems associated with MS including visual loss, double vision and shaky vision.

Listen

Multiple Sclerosis Biomarkers including Blood Tests

Series Sponsored by Octave. With current tools, changes in multiple sclerosis (MS) disease activity are often invisible until it's too late. On the latest MS Living Well podcast, Dr. Barry Singer & special guest, Dr. Chitnis, discuss biomarkers and blood tests to measure MS disease activity. With Octave's first and only market-ready MS disease activity blood-based biomarker test, we're proud to sponsor this week's episode as we celebrate advancements in MS care.

Listen

Aging & Multiple Sclerosis

Series Sponsored by Octave. As we age, our immune systems become less robust. People need strategies to live better with MultipleSclerosis as they grow older. On the latest MS Living Well Podcast, Dr. Barry Singer and special guests, Dr. Weinstock-Guttman & Dr. Corboy, discuss multiple considerations to navigate aging and MS well.

Listen

Diet & Multiple Sclerosis

Series sponsored by Octave. When it comes to your health, one diet will not fit all; especially when living with Multiple Sclerosis. Dr. Ellen Mowery, Professor of Neurology and Epidemiology at John Hopkins, and Dr. Ilana Katz Sand, Associate Professor of Neurology at Mount Sinai, join Barry Singer, MD and discuss MS & dieting on the latest MS Living Well podcast.

Listen

Multiple Sclerosis: Cause & Cure

Series sponsored by Octave. Listen to Barry Singer, MD, and other industry experts discuss the cause and cure for multiple sclerosis as well as the link to the Epstein-Barr virus (EBV).

Listen

The Alldus Podcast - AI in Action

The AI in Action series of The Alldus Podcast breaks down the hype and explores the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives. Hear from our very own Chief Technology Officer Erwan Rivet, a recent guest.

Listen

Connecting on World MS Day

Octave Bioscience proudly partnered with Olink Proteomics for an in-depth technical webinar featuring Ferhan Qureshi, VP of Biomarker Product Development at Octave, highlighting the importance of creating connections between organizations shaping MS research.

Watch

Managing Neurodegenerative Diseases with Better Data to Improve Outcomes

Bill Hagstrom, CEO, spoke to The Bio Report about the Octave's efforts to harness novel measurements of disease to individualize care, the case we're making with payers, and why we're starting with MS.

Listen

Get in Touch

Please reach out and we’ll be in touch soon.

Get in Touch